CJC1295 without-DAC 5mg

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) engineered for extended half-life and sustained bioactivity. Unlike native GHRH, CJC-1295 incorporates a Drug Affinity Complex (DAC) technology that enables covalent binding to serum albumin, significantly prolonging its activity in research models. It functions by stimulating the pituitary gland to increase secretion of growth hormone (GH) and, subsequently, insulin-like growth factor 1 (IGF-1). CJC-1295 is widely studied for its role in growth hormone axis modulation, making it a subject of considerable interest in research related to body composition, metabolic function, tissue repair, and age-related hormonal decline. For research purposes only.